Your browser doesn't support javascript.
loading
Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.
Novelli, Deborah; Fumagalli, Francesca; Staszewsky, Lidia; Ristagno, Giuseppe; Olivari, Davide; Masson, Serge; De Giorgio, Daria; Ceriani, Sabina; Affatato, Roberta; De Logu, Francesco; Nassini, Romina; Milioli, Marco; Facchinetti, Fabrizio; Cantoni, Silvia; Trevisani, Marcello; Letizia, Teresa; Russo, Ilaria; Salio, Monica; Latini, Roberto.
Afiliação
  • Novelli D; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Fumagalli F; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Staszewsky L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Ristagno G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Olivari D; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Masson S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • De Giorgio D; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Ceriani S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Affatato R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • De Logu F; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, 50139, Florence, Italy.
  • Nassini R; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, 50139, Florence, Italy.
  • Milioli M; Chiesi Farmaceutici S.p.A, Corporate Pre-Clinical R&D, Largo F. Belloli 11/A, 43122, Parma, Italy.
  • Facchinetti F; Chiesi Farmaceutici S.p.A, Corporate Pre-Clinical R&D, Largo F. Belloli 11/A, 43122, Parma, Italy.
  • Cantoni S; Chiesi Farmaceutici S.p.A, Corporate Pre-Clinical R&D, Largo F. Belloli 11/A, 43122, Parma, Italy.
  • Trevisani M; Chiesi Farmaceutici S.p.A, Corporate Pre-Clinical R&D, Largo F. Belloli 11/A, 43122, Parma, Italy.
  • Letizia T; Endocrinology Laboratory, Luigi Sacco Hospital, Via Giovanni Battista Grassi 74, 20157, Milan, Italy.
  • Russo I; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Salio M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy.
  • Latini R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milan, Italy. Electronic address: roberto.latini@marionegri.it.
Eur J Pharmacol ; 865: 172777, 2019 Dec 15.
Article em En | MEDLINE | ID: mdl-31697933

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Sulfonamidas / Inibidores de Proteínas Quinases / Quinases Associadas a rho / Antagonistas dos Receptores de Endotelina / Amidas / Hipertensão Arterial Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Sulfonamidas / Inibidores de Proteínas Quinases / Quinases Associadas a rho / Antagonistas dos Receptores de Endotelina / Amidas / Hipertensão Arterial Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2019 Tipo de documento: Article